GCL
AMED

Glazer Capital LLC’s Amedisys AMED Stock Holding History

Glazer Capital LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,669
Closed -$4.39M – 307
2025
Q2 		$4.39M Buy
+44,669
New +$4.23M 0.16% 95

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's AMED Position: Q3 2025 in Review

Glazer Capital LLC sold out of Amedisys (AMED) in Q3 2025, closing a stake of 44,669 shares — an estimated $4.39M sold.

Glazer Capital LLC first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $4.39M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Glazer Capital LLC reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 44,669 Amedisys shares in Q3 2025, an estimated $4.39M.
  • Glazer Capital LLC first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Glazer Capital LLC's Amedisys position peaked at $4.39M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Glazer Capital LLC's 13F filing for Q3 2025, filed 13 Nov 2025.